Furthermore, the proliferation of tumor cells was significantly reduced when STAT1 was either knocked down or inhibited, suggesting that the abnormal activation of STAT1 is a crucial factor in the pathogenesis of ETV6-NTRK3-positive tumors. This evidence concerns the gene NTRK3 and neoplasm.